SRPT icon

Sarepta Therapeutics
SRPT

Overview Fund Activity

357 hedge funds and large institutions have $1.42B invested in Sarepta Therapeutics in 2025 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 159 increasing their positions, 86 reducing their positions, and 128 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
357
Holders Change
-69
Holders Change %
-16.2%
% of All Funds
4.79%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
64
Increased
159
Reduced
86
Closed
128
Calls
$132M
Puts
$79.5M
Net Calls
+$52.1M
Net Calls Change
+$31M

Top Buyers

1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$76.5M
2
BlackRock
BlackRock
New York
+$37.8M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$29.2M
4
Two Sigma Investments
Two Sigma Investments
New York
+$27.5M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$26.8M

Top Sellers

1
ACA
Avoro Capital Advisors
New York
-$171M
2
FCM
Farallon Capital Management
California
-$149M
3
Capital International Investors
Capital International Investors
California
-$146M
4
EC
EcoR1 Capital
California
-$82.5M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$56.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
SWM
476
Spire Wealth Management
Virginia
– -$511 -8 Closed
LWCFA
477
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– -$416 -7 Closed
CH
478
Cromwell Holdings
Wyoming
– -$383 -6 Closed
GFPC
479
Global Financial Private Client
Florida
– -$255 -4 Closed
RFS
480
Richardson Financial Services
Massachusetts
– -$255 -4 Closed
HWP
481
Highline Wealth Partners
California
– -$128 -2 Closed
GAM
482
Groupama Asset Management
France
– -$1.23M – –
16 17 18 19
20